Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Tubercidin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Specimen Handling 472 pembrolizumab 453 Magnetic Resonance Spectroscopy 410 Carboplatin 323 Cyclophosphamide 303 Cisplatin 267 Biopsy 265 Radiotherapy 235 Paclitaxel 224 Gemcitabine 223 Bevacizumab 216 Nivolumab 191 venetoclax 185 fludarabine 174 Drug Therapy 166 Dexamethasone 161 Blood Specimen Collection 160 Injections 153 Oxaliplatin 147 Docetaxel 145 Fluorouracil 144 Capecitabine 140 Standard of Care 134 Radiosurgery 131 Rituximab 127 Pemetrexed 125 atezolizumab 114 durvalumab 112 Leucovorin 109 Radiation 106

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡